Kicking Cancer's Ass: Been Awhile

Hello all - has been a long time since my last confession - oops that is for church.. I mean it has been a long time since my last post.

I am doing well - dealing with allot of graft VS host -

One Of My Favorite Tunes

Hello my friend we meet again
It's been a while where should we begin ...
feels like forever.......
Within my heart are memories of perfect love that you gave to me
OH, I remember

Chorus:
When you are with me I'm free...I'm careless...I believe
Above all the others we'll fly This brings tears to my eyes

My Sacrifice

We've seen our share of up's and down's
Oh, how quickly life can turn around ... in an instantIt feels so good to reunite within yourself and within your mind
Let's find peace there
When you are with me I'm free...I'm careless...I believe Above all the others we'll fly This brings tears to my eyes
My Sacrifice

I just want to say hello again I just want to say hello again
When you are with me I'm free...I'm careless...I believe
Above all the others we'll fly This brings tears to my eyes
When you are with meI'm free...I'm careless...I believeAbove all the others we'll fly This brings tears to my eyes When you are with me

My sacrafice

I just want to say hello againI just want to say hello again

My sacrifice

New Cancer Fighting Drug Begins Phase I Testing: May Provide Patients with Chemotherapy Alternative

A new clinical trial is underway to study a cancer drug known as EP-100 in patients with skin, ovarian, breast, prostate, endometrial and pancreatic cancer.
The Phase 1 trial will study 36 adult patients who have had biopsies that demonstrate high levels of the luteinizing releasing hormone receptors (LHRH), a prominent characteristic of cancer cells. Scientists will give patients a specific amount of EP-100 through an intravenous method for three out of the four week study.
The goal of EP-100 is to be a membrane disrupting peptide (tMDP) that goes after specific cancer cells in patients with solid tumors. Researchers are testing the drug to perform a routine they call “seek and destroy,” which will go after cells in one’s body that may have increased amounts of LHRH.
Preliminary results from the pre-clinical trials held in ovarian cancer cell lines were presented at the American Association for Cancer Research (AACR) annual meeting, located in Denver, CO. Physicians and researchers are hopeful that the drug will be a huge advancement for uterine and ovarian cancer patients. Many patients with advanced cancer will require new treatments and EP-100 may be the next paradigm of research.
Studies with mice have shown a decrease in size of tumors in people with several different types of cancer. Researchers are hopeful that EP-100 will be effective for patients and become a solidified alternative to chemotherapy and radiation with less negative results. The most uplifting news yet show that this drug does not harm normal, healthy cells, which may lead to higher standards to existing cancer therapies.
By providing FDA alerts, drug information, drug interactions and the latest news about prescription, over the counter medications and clinical trials, we can ensure an environment where patients have the best knowledge on their medical treatment and health.

Kicking Cancer's Ass

Sunday, January 22, 2012

Been Awhile

No comments:

Post a Comment

Slideshow

What Cancer Cannot Do

Followers

About Me

Email Me

Poem - My Sister - My Donor found and Gave me

Live Life

One Of My Favorite Tunes

Facebook Badge

New Cancer Fighting Drug Begins Phase I Testing: May Provide Patients with Chemotherapy Alternative

Kicking Cancer's Ass

Sunday, January 22, 2012

Been Awhile

No comments:

Post a Comment

Slideshow

What Cancer Cannot Do

Followers

About Me

Email Me

Poem - My Sister - My Donor found and Gave me

Live Life

One Of My Favorite Tunes

Subscribe To The Buzzman's Blog

Facebook Badge

New Cancer Fighting Drug Begins Phase I Testing: May Provide Patients with Chemotherapy Alternative